Table 1.
Baseline characteristics in 32 gastroenteropancreatic neuroendocrine tumors (GEP-NETs) patients.
| Variables | n | % |
|---|---|---|
| Gender | ||
| Male | 18 | 56.3 |
| Female | 14 | 43.7 |
| Age, years | ||
| Median, range | 60, (35-88) | |
| Primary tumor site | ||
| Stomach | 1 | 3.1 |
| Duodenum | 2 | 6.2 |
| Gall Bladder | 6 | 18.8 |
| Biliary | 1 | 3.1 |
| Pancreas | 14 | 43.8 |
| Rectum | 8 | 25.0 |
| WHO classification | ||
| Grade II neuroendocrine tumor | 15 | 46.9 |
| Grade III neuroendocrine carcinoma | 17 | 53.1 |
| Liver metastasis | ||
| Yes | 32 | 100.0 |
| Number of metastatic sites | ||
| 1 | 11 | 34.4 |
| 2 ≤ | 21 | 65.6 |
| First line treatment | ||
| Only supportive care | 7 | 21.9 |
| Systemic treatment | 25 | 78.1 |